Published ahead of print on January 27, 2005, doi:10.1165/rcmb.2004-0205OC
Am. J. Respir. Cell Mol. Biol., Volume 32, Number 5, May 2005, 470-477
A more recent version of this article appeared on May 1, 2005
Submitted on June 24, 2004
Revised on January 24, 2005
KGF expression by fibroblasts in pulmonary fibrosis: poor response to interleukin-1 beta
Sylvain Marchand-Adam1, Laurent Plantier1, Dominique Bernuau2, Agnes Legrand2, Murielle Cohen3, Joelle Marchal1, Paul Soler1, Guy Leseche4, Herve Mal5, Michel Aubier6, Monique Dehoux3, and Bruno Crestani6*
1 Unit 700, INSERM, Paris, France,
2 Unit 327, INSERM, Paris, France,
3 Unit 700, INSERM, Paris, France; Service de biochimie 1, Hopital Bichat, Assistance Publique-Hopitaux de Paris, Paris, France,
4 Service de Chirurgie thoracique et cardio-vasculaire, Hopital Beaujon, Assistance Publique-Hopitaux de Paris, Clichy, France,
5 Unit 700, INSERM, Paris, France; Service de Pneumologie, Hopital Beaujon, Assistance Publique-Hopitaux de Paris, Clichy, France,
6 Unit 700, INSERM, Paris, France; Service de Pneumologie, Hopital Bichat, Assistance Publique-Hopitaux de Paris, Paris, France
* To whom correspondence should be addressed. E-mail: bruno.crestani{at}bch.ap-hop-paris.fr.
Keratinocyte growth factor (KGF) is secreted by fibroblasts and protects from pulmonary fibrosis in animal models. IL-1 is the most potent inducer of KGF in fibroblasts, acting through the c-Jun pathway. We evaluated in vitro KGF production by human lung fibroblasts from patients with idiopathic pulmonary fibrosis (IPF, n=10) and from controls (n=7) at baseline and after IL-1 stimulation. Basal KGF secretion by IPF fibroblasts was similar to controls. In controls fibroblasts, IL-1 increased c-Jun expression, c-Jun activation, and KGF secretion. SP600125, a specific c-Jun N terminal kinase (JNK) inhibitor, inhibited the effect of IL-1 . By contrast, in IPF fibroblasts, IL-1 did not increase c-Jun expression and c-Jun activation, and weakly increased KGF secretion, whereas SP600125 had no effect. IL-1 similarly increased JunB expression in IPF and controls fibroblasts. Total JNK content was not different in either unstimulated or IL-1 stimulated IPF and control fibroblasts. IL-1 increased phosphorylated JNK in control and IPF fibroblasts, but this increase was weaker and heterogeneous in IPF. Altogether, our results demonstrate a dysregulation of KGF secretion by IPF fibroblasts. The weak response to IL-1 is associated with a defect of c-Jun expression and activation and a defect of JNK activation.
This article has been cited by other articles:

|
 |

|
 |
 
R Borie, A Fabre, F Prost, J Marchal-Somme, R Lebtahi, S Marchand-Adam, M Aubier, P Soler, and B Crestani
Activation of somatostatin receptors attenuates pulmonary fibrosis
Thorax,
March 1, 2008;
63(3):
251 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Marchal-Somme, Y. Uzunhan, S. Marchand-Adam, M. Kambouchner, D. Valeyre, B. Crestani, and P. Soler
Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease
Am. J. Respir. Crit. Care Med.,
November 15, 2007;
176(10):
1007 - 1014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marchand-Adam, A. Fabre, A. A. Mailleux, J. Marchal, C. Quesnel, H. Kataoka, M. Aubier, M. Dehoux, P. Soler, and B. Crestani
Defect of Pro-Hepatocyte Growth Factor Activation by Fibroblasts in Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
July 1, 2006;
174(1):
58 - 66.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society.
|
|
|